Nipro Corp. (TYO:8086) and NeuroMetrix Inc. (NSDQ:NURO) announced a collaboration to market NeuroMetrix’s NC-stat diagnostic nerve testing device. The NC-stat test is a quantitative point-of-care test that evaluates systemic neuropathies like diabetic peripheral neuropathy, a common disease affecting more than half of diabetics which may lead to foot ulcers and limb amputation. This may be […]
Imagine if your in-car infotainment system could also alert you when your blood glucose levels were low. Ford and Medtronic (NYSE:MDT) have launched such a project. The automaker has teamed with the developer of new innovative medical devices on a research project to deliver health information as people drive. Services and apps will target people […]
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Medtronic Inc. and Bayer HealthCare, part of Bayer AG, announced Monday that they have expanded an international alliance to now include the U.S. market in a bid to tackle diabetes. Since 2007, the Fridley, Minnesota company, which makes new innovative medical devices, and the Tarrytown, New York company have partnered overseas in more than 20 countries. […]
Intellectual property protection for DARA BioSciences‘s drug pipeline just got a little more secure. Raleigh, North Carolina-based DARA (NASDAQ:DARA) has been issued nine patents in the United States and around the world, which gives it additional intellectual property protection for compounds being developed as new treatments for diabetes, obesity, cardiovascular disease and pain. DARA does […]
Obesity’s link to diabetes is well documented and it comes as no surprise that bariatric surgery helps. But new research from Duke University and Columbia University finds that the weight loss surgery works in a way that is quite unexpected. Results of a study published in Science Translational Medicine show that bariatric surgery results in […]
Roseville, Minnesota-based EnteroMedics said Monday, that it expects to implant its first patient with its obesity controlling therapy by the second quarter of the year and all implants completed by year end. The announcement was part of the anti-obesity device maker’s first quarter results in which the company reported a loss of $5.1 million, or […]
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Medtronic (NYSE:MDT) said its software that patients use to assess their blood glucose control is now compatible with Mac operating systems, reports Diabetes Health. The U.S. Food and Drug Administration approved the CareLink Personal 5.4 Therapy Management Software for Apple computers and it has been available since early April, according to the Medtronic Diabetes website. […]
To combat the obesity epidemic, the National Institutes of Health is encouraging diverse scientific investigations through a new Strategic Plan for NIH Obesity Research. More than one-third of adults in the United States and nearly 17 percent of the nation’s children are now obese, which increases a person’s chance of developing many health problems, including […]
A new strategic plan to guide diabetes-related research over the next decade was announced recently by the National Institutes of Health. The plan, developed by a federal work group led by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), identifies research opportunities with the greatest potential to benefit the millions of Americans […]
Next-generation insulin developer Thermalin Diabetes has closed a $2.85 million Series A investment round. The Cleveland-based startup plans to use the funding to step up production of its insulin analogs — new proteins engineered to act like insulin in the body — and continue preclinical testing. The insulin analogs are heat resistant, unlike the natural […]
We will highlight Build My Health's revenue practice management tools, which could help physician practices add up to $250,000 to their practices.
After starting out as a community-building site for diabetics, Diabetes Daily is branching out into education. The company plans to launch its new Diabetes Daily University this summer.
Obesity and diabetes are among the most challenging health problems in the United States. MetaModix is developing a minimally invasive alternative to bariatric surgery, which would be an out-patient procedure that would last about 30 minutes.
Allergan's Lap-Band will now be available for a new group of obese patients. It used to be available only to people with a body mass index of 40 or at least 100 pounds over their ideal weight. Now, patients with a body mass index as low as 30 may be eligible to use the innovative medical device for weight loss. The announcement could increase sales by 51 percent to at least $390 million by 2016.
London-based Cellnovo closes $48 million B round to fund commercialization of the first all mobile diabetes management system, which is drawing comparisons to Apple Inc.'s blockbuster iPhone and iPod platforms.
Muve was Minnesota's "breakthrough business idea" of 2007. The obesity-fighting fitness device concept was the unanimous winner of that year's Minnesota Cup contest, earning it prize money and piles of positive press. Not only that, the startup had a big-name partner behind it in the Mayo Clinic. So why did the company fail?